Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study

被引：0
|
作者：
Miao, J. [1 ]
Hu, C. [2 ]
Lin, S. [3 ,4 ]
Chen, X. [5 ]
Chen, Y. [6 ]
Zhong, Y. [7 ]
Jin, F. [8 ]
Lin, Q. [9 ]
Hu, X. [10 ]
Zhang, N. [10 ]
Wang, R. [11 ]
Wang, L. [12 ]
Wang, C. [13 ]
Zhu, M. [13 ]
Wu, H. [13 ]
Di, M. [13 ]
Huang, Y. [13 ]
Xie, C. [7 ]
Zhao, C. [14 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[3] Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China
[4] Fujian Med Univ, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Canc Hosp, Zhejiang Key Lab Radiat Oncol, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China
[7] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Hubei, Peoples R China
[8] Guizhou Med Univ, Guiyang, Guizhou, Peoples R China
[9] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[10] First Peoples Hosp Foshan, Guangzhou, Guangdong, Peoples R China
[11] Guangxi Tumor Radiat Therapy Clin Med Res Ctr, Nanning, Peoples R China
[12] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[13] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[14] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Guangdong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO_33_2782
引用
收藏
页码：E334 / E334
页数：1
相关论文
共 50 条
  • [31] A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
    Chen, Y. P.
    Wang, Z. X.
    Chen, L.
    Liu, X.
    Tang, L. L.
    Mao, Y. P.
    Li, W. F.
    Lin, A. H.
    Sun, Y.
    Ma, J.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (01) : 205 - 211
  • [32] Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma
    Chen, Lin
    Li, Kunpeng
    Li, Qingjie
    Ji, Pengjie
    Huang, Chenglong
    Tang, Linglong
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [33] Concurrent Chemoradiotherapy (CCRT) followed by adjuvant chemotherapy (CTX) in the treatment of locoregionally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT)
    Bacoyiannis, Charalabos
    Katsikas, Michael
    Klouvas, George
    Matsouka, Fotini
    Kolitsi, Georgia
    Katsohi, Despina
    Kyprianou, Costas
    Skarlos, Dimosthenis
    Kosmidis, Paris
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 141 - 141
  • [34] Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
    Ya-Nan Jin
    Hui-Jiao Cao
    Xiao-Hua Gong
    Wang-Jian Zhang
    Tia Marks
    Ji-Jin Yao
    Liang-Ping Xia
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2569 - 2579
  • [35] Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
    Jin, Ya-Nan
    Cao, Hui-Jiao
    Gong, Xiao-Hua
    Zhang, Wang-Jian
    Marks, Tia
    Yao, Ji-Jin
    Xia, Liang-Ping
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2569 - 2579
  • [36] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Feng, Hui-Xia
    Guo, Su-Ping
    Li, Gui-Rong
    Zhong, Wen-Huan
    Chen, Liu
    Huang, Li-Ru
    Qin, Hui-Ying
    [J]. MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 6
  • [37] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Hui-Xia Feng
    Su-Ping Guo
    Gui-Rong Li
    Wen-Huan Zhong
    Liu Chen
    Li-Ru Huang
    Hui-Ying Qin
    [J]. Medical Oncology, 2014, 31
  • [38] Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma
    Liu, H.
    Ding, X. R.
    Song, Y. Q.
    Jiang, C.
    Zhong, X. M.
    Hui, H. X.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 2115 - 2119
  • [39] Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma Interim Results From 2 Prospective Phase 2 Clinical Trials
    Kong, Lin
    Hu, Chaosu
    Niu, Xiaoshuang
    Zhang, Youwang
    Guo, Ye
    Tham, Ivan W. K.
    Lu, Jiade Jay
    [J]. CANCER, 2013, 119 (23) : 4111 - 4118
  • [40] Concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: is Intergroup Study 0099 feasible in Japanese patients?
    Isobe, K
    Kawakami, H
    Uno, T
    Yasuda, S
    Aruga, T
    Ueno, N
    Kawata, T
    Ito, H
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (10) : 497 - 500
12345